Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
Artisan Small Cap Fund Q4 2025 Portfolio Activity
09:08am, Friday, 23'rd Jan 2026
During the quarter, we initiated new positions in nLIGHT, Guardant Health and Cellebrite. We also added to Bruker, Hexcel and Penumbra during the quarter. Along with Insmed, we also ended our investme
Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights
12:41am, Wednesday, 21'st Jan 2026
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Halper Sadeh LLC Encourages PEN, CVGW, AVO Shareholders to Contact the Firm to Discuss Their Rights
12:45pm, Saturday, 17'th Jan 2026
NEW YORK, Jan. 17, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breac
NEW YORK and NEW ORLEANS, Jan. 16, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Penumbra (PEN) Moves 11.8% Higher: Will This Strength Last?
06:51am, Friday, 16'th Jan 2026
Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in th
Market Today: TSMC beat, Goldman soars, Spotify hikes
05:35pm, Thursday, 15'th Jan 2026
Stock News Verizon issues credits after outage: Verizon (VZ) said it resolved a nationwide wireless outage and will offer a $20 account credit to affected custo
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)
03:30pm, Thursday, 15'th Jan 2026
NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders an
Boston Scientific's $14.5B Acquisition of Penumbra Raises Investor Concerns
12:14pm, Thursday, 15'th Jan 2026
Boston Scientific (BSX) is experiencing a significant drop in its stock price after announcing its plan to acquire Penumbra (PEN) in a deal worth approximately
Boston Scientific to acquire Penumbra in $14.5B deal
12:05pm, Thursday, 15'th Jan 2026
Boston Scientific Corp (NYSE:BSX, XETRA:BSX) announced a definitive agreement to acquire medical device company Penumbra (NYSE:PEN) in a cash and stock transaction valuing Penumbra at $374 per share,
BALA CYNWYD, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j
Active Energy shares move to OTCID market in US
10:40am, Thursday, 15'th Jan 2026
Active Energy Group PLC (AIM:AEG, OTCQB:ATGVF) said its shares have moved from the OTCQB Venture Market to the OTC Integrated Disclosure Market in the...
Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders
10:27am, Thursday, 15'th Jan 2026
MILWAUKEE, Jan. 15, 2026 /PRNewswire/ -- Ademi LLP is investigating Penumbra (NYSE: PEN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with
Boston Scientific Agrees to Buy Penumbra in $14.6 Billion Cardiovascular Deal
10:17am, Thursday, 15'th Jan 2026
Boston Scientific Corp. (BSX) said it has agreed to acquire Penumbra Inc. (PEN) in a transaction valued at more than $14 billion, marking a significant step in
Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach
09:11am, Thursday, 15'th Jan 2026
Boston Scientific on Thursday announced plans to acquire Penumbra, a US-based thrombectomy specialist, in a cash-and-stock deal valued at about $14.5 billion, marking one of the largest transactions i
Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.
08:45am, Thursday, 15'th Jan 2026
The cash-and-stock acquisition values Penumbra at $374 a share.
